Skip to main content
Download PDF

Interaction studies on catecholamines to cellular receptors using in silico approach

Artery Research volume 19, pages 29–37 (2017)Cite this article

Abstract

Catecholamines are organic compounds derived from amino acids tyrosine and phenylalanine, which acts as neurotransmitters and also functions as hormones in the blood circulation. They bind to plasma proteins and circulate in the blood stream. High levels of catecholamines will cause increase in the heart rate, blood pressure and blood glucose level. These effects are due to binding of catecholamines with adrenergic receptors. Therefore the objective of the current research work is to know the binding affinity of catecholamines with adrenergic receptors through in silico approach. For this study, four catecholamines and three adrenergic receptors were selected for binding analysis. The three natural catecholamines are epinephrine, nor-epinephrine, dopamine and a synthetic catecholamine is Isoproterenol. The three selected receptors are 1GQ4, 3D4S and 1BAK. Binding effect of the four neurotransmitters with the three receptors was studied through in silico analysis using softwares. PATCH DOCK and Z DOCK online servers were used to analyze the docking scores and internal energy was observed by Accelrys Discovery studio. From this study the synthetic catecholamine Isoproterenol showed maximum binding score with all three adrenergic receptors comparing to 3 natural catecholamines. The internal energy of Isoproterenol was found to be 35.18127 kJ/mol. Therefore the study concludes the synthetic catecholamine Isoproterenol has more binding affinity towards beta adrenergic receptors comparing to natural catecholamines. Hence, the current study suggests the usage of synthetic catecholamines will have more binding affinity with adrenergic receptors which could be further analyzed using in vivo study as a future work.

References

  1. McDonald T, Hoffman WE, Berkowitz R, Cunningham F, Cooke B. Heart rate variability and plasma catecholamines in patients during opioid detoxification. J Neurosurg Anesthesiol 1999;11(3):195–9.

    Google Scholar 

  2. Schweigert FJ, Buchholz I, Schuhmacher A, Gropp J. Effect of dietary beta-carotene on the accumulation of beta-carotene and vitamin A in plasma and tissues of gilts. Reprod Nutr Dev 2001;41(1):47–55.

    Google Scholar 

  3. Dean T. Cow’s milk allergy: therapeutic options and immunological aspects. Eur J Clin Nutr 1995;49(Suppl 1):S19–25.

  4. Russell MA, Wilson C, Patel UA, Cole PV, Feyerabend C. Comparison of effect on tobacco consumption and carbon monoxide absorption of changing to high and low nicotine cigarettes. Br Med J 1973;4(5891):512–6.

    Google Scholar 

  5. Elliott J. Alpha-adrenoceptors in equine digital veins: evidence for the presence of both α1 and α2-receptors mediating vasoconstriction. J Vet Pharmacol Ther 1997;20(4):308–17.

    Google Scholar 

  6. Joh TH, Hwang O. Dopamine beta-hydroxylase: biochemistry and molecular biology. Ann N. Y Acad Sci 1987;493:342–50.

    Google Scholar 

  7. Young WF. Adrenal medulla, catecholamines, and pheochromocytoma. In: Goldman L, Ausiello D, editors. Cecil medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007. chap. 246.

  8. Meyers Stephen. Use of neurotransmitter precursors for treatment of depression. Altern Med Rev 2000;5(1):64–71.

    Google Scholar 

  9. Sapolsky R. Biology and human behavior: the neurological origins of individuality. In: The teaching company. 2nd ed. 2005. pages 13 & 14 of Guide Book.

  10. Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 2000;43:3714–7.

    Google Scholar 

  11. Lengauer T, Rarey M. Computational methods for biomolecular docking. Curr Opin Struct Biol 1996;6(3):402.

    Google Scholar 

  12. Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson HJ. Servers for rigid and symmetric docking. Nucl Acids Res 2005; 33:363–7.

    Google Scholar 

  13. Axelrod J, Hertting G, Potter LT. Effect of drugs on the uptake and release of H3-norepinephrine in the rat heart. Nature 1962:194–297.

  14. Whitby LG, Hertting G. Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues. Science 1961;133: 383–4.

    Google Scholar 

  15. Cass R, Kuntzman R, Brodie B. Norepinephrine depletion as a possible mechanism of action of guanethidine (SU 5864), a new hypotensive agent. Proc Soc Exp Biol 1960;103:871–2.

    Google Scholar 

  16. Chang CC, Costa E, Brodie BB. Interaction of guanethidine with adrenergic neurons. J Pharmacol Exp Ther 1965;147:303–12.

    Google Scholar 

  17. Corrodi H, Fuxe K, Hamberger B, Ljungdahl A. Studies on central and peripheral noradrenaline neurons using a new dopamine-ß-hydroxylase inhibitor. Eur J Pharmacol 1970;12: 145–55.

    Google Scholar 

  18. Ahlquist RP. A study of the adenotrophic receptors. Am J Physiol 1948;153:586–600.

  19. Golan David E. Principles of pharmacology: the pathophysiologic basis of drug therapy. 2nd ed. 2008.

  20. Katzung B. Basic & clinical pharmacology. Mc Graw Hill Medical. 10th ed.

  21. Harvey Richard, Champe Pamela. Lippincott illustrated reviews: Pharmacology. 4th ed. LWW; 2007.

  22. Huang J, Zong Y, Goldstein AS. Distinct roles for Src tyrosine kinase in beta2-adrenergic receptor signaling to MAPK and in receptor internalization. J Biol Chem 2004;279:21637–42162.

    Google Scholar 

  23. Zhong J, Zhang Y. Beta-Adrenergic receptor stimulation of L-type Ca2+ channels in rabbit portal vein myocytes involves both alphas and betagamma G protein subunits. J Physiol 2001; 531:105–15.

    Google Scholar 

  24. Accelrys discovery Studio ‘Discovery Studio 2.0 Accelrys Life Science Tool’ Accelrys Discovery Studio site - http://www.accelerys.com.

  25. Binkowski AT, Naghibzadeh S, Liang J. CASTp: computed atlas of surface topography of proteins. Nucleic Acids Res 2003;31: 3352–5.

    Google Scholar 

  26. Katzung B. Basic & clinical pharmacology. 10th ed. Mc Graw Hill Medical; 2007.

  27. Harvey Richard, Champe Pamela. Lippincott illustrated reviews: Pharmacology. 4th ed. 2009.

  28. Alfred Allen. Commercial organic analysis. London: J & A Churchill; 1889. p. 65.

  29. Shen Howard. Illustrated pharmacology memory cards: PharMnemonics. Minireview. 2008. p. 5.

  30. Manger WM. An overview of pheochromocytoma: history, current concepts, vagaries, and diagnostic challenges. Ann N. Y Acad Sci 2006;1073:1–20.

    Google Scholar 

  31. Reisch N, Peczkowska M, Januszewicz A, Neumann HP. Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens 2006;24(12):2331–9.

    Google Scholar 

  32. Prejbisz A, Lenders JW, Eisenhofer G, Januszewicz A. Cardiovascular manifestations of phaeochromocytoma. J Hypertens 2011;29(11):2049–60.

    Google Scholar 

  33. Coroleu SF, Munoz-Camacho JF, Fernandez-Gomez C, Tarroch-Sarasa X. Acute myocardial infarction probably related to severe coronary vasospasm during pheochromocytoma crisis. Rev Esp Cardiol 2011;64(3):244–6.

    Google Scholar 

  34. Mittleman MA, Mintzer D, Maclure M, Tofler GH, Sherwood JB, Muller JE. Triggering of myocardial infarction by cocaine. Circulation 1999;99(21):2737–41.

    Google Scholar 

  35. Khorram-Manesh A, Ahlman H, Nilsson O, Friberg P, Oden A, Stenstrom G. Long-term outcome of a large series of patients surgically treated for pheochromocytoma. J Intern Med 2005; 258(1):55–66.

    Google Scholar 

  36. Ilias I, Shulkin B, Pacak K. New functional imaging modalities for chromaffin tumors, neuroblastomas and ganglioneuromas. Trends Endocrinol Metab 2005;16(2):66–72.

    Google Scholar 

  37. Muscholl E. Effect of cocaine and related drugs on the uptake of noradrenaline by heart and spleen. Br J Pharmacol Chemother 1961;16:352–9.

    Google Scholar 

  38. Roghi A, Pedrotti P, Milazzo A, Bonacina E, Bucciarelli-Ducci C. Adrenergic myocarditis in pheochromocytoma. J Cardiovasc Magn Reson 2011;13:4.

    Google Scholar 

  39. Richard C. Stress-related cardiomyopathies. Ann Intensive Care 2011;1(1):39.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biotechnology, Sri Venkateswara College of Engineering, 602117, Sriperumbudur, Tamil Nadu, India

    S. Kalaivannan, T. Vinoth kambali, S. Prabhu, S. Visvanathan & N. Karpagam

Authors
  1. S. Kalaivannan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Vinoth kambali
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Prabhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Visvanathan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N. Karpagam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Prabhu.

Rights and permissions

This is an open access article distributed under the CC BY-NC license. https://doi.org/creativecommons.org/licenses/by/4.0/

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kalaivannan, S., kambali, T.V., Prabhu, S. et al. Interaction studies on catecholamines to cellular receptors using in silico approach. Artery Res 19, 29–37 (2017). https://doi.org/10.1016/j.artres.2017.06.001

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.artres.2017.06.001

Keywords

Artery Research

ISSN: 1876-4401

Contact us